EQUITY |
6 Months Ended | |||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2025 | ||||||||||||||||||||||||||||||||||
EQUITY | ||||||||||||||||||||||||||||||||||
EQUITY | NOTE 11. EQUITY
Common Stock
As of June 30, 2025, the Company had 4,500,000,000 authorized shares of Common Stock with a par value of $0.001. As of June 30, 2025, and December 31, 2024, there were 110,682,750 and 109,369,075 shares of Common Stock issued and outstanding, respectively.
2025 Issuances
During the six months ended June 30, 2025 the Company issued the following common shares:
2024 Issuances
During the year ended December 31, 2024 the Company issued the following common shares:
Preferred Stock
During 2020 the Company had 855,000 shares of Preferred Series A Stock outstanding. This Class of Preferred Stock had a 1 for 1 conversion ratio to common stock. During 2021 this class of Series A Preferred Stock was converted to 855,000 shares of common stock prior to the reverse split. On a post-split basis of 250 to 1, this amounted to 3,420 common shares. In March 2021 the Company designated a new class of Series A Preferred Stock.
As of June 30, 2025, the Company has authorized 300,000,000 shares of Preferred Series A Stock. As of June 30, 2025, and December 31, 2024, there were 226,206,479 and 226,206,479 Preferred Series A shares issued and outstanding, respectively. Each share of preferred stock is convertible to 50 shares of common stock. |